168 related articles for article (PubMed ID: 37859585)
1. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
[TBL] [Abstract][Full Text] [Related]
2. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
3. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway.
Wang T; Chen Z; Chen H; Yu X; Wang L; Liu X
J Ethnopharmacol; 2022 Apr; 288():115020. PubMed ID: 35066068
[TBL] [Abstract][Full Text] [Related]
4. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
Zhang YJ; Zhang L; Feng F; Cao QF
Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
[TBL] [Abstract][Full Text] [Related]
5. MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.
Xiao Q; Gan Y; Li Y; Fan L; Liu J; Lu P; Liu J; Chen A; Shu G; Yin G
Oncogene; 2021 May; 40(19):3364-3377. PubMed ID: 33863999
[TBL] [Abstract][Full Text] [Related]
6. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling.
Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J
Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
8. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
Cai F; Li J; Zhang Y; Huang S; Liu W; Zhuo W; Qiu C
BMC Cancer; 2024 Feb; 24(1):175. PubMed ID: 38317072
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Von Schulz-Hausmann SA; Schmeel LC; Schmeel FC; Schmidt-Wolf IG
Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
[TBL] [Abstract][Full Text] [Related]
11. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
12. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract][Full Text] [Related]
13. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
14. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.
Xie J; Zhou J; Xia J; Zeng Y; Huang G; Zeng W; Fan T; Li L; Zeng X; Tao Q
Clin Epigenetics; 2023 Feb; 15(1):30. PubMed ID: 36849889
[TBL] [Abstract][Full Text] [Related]
16. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
18. KLK4 Silencing Inhibits the Growth of Chromophobe Renal Cell Carcinoma through ERK/AKT Signaling Pathway.
Fan B; Niu Y; Zhang A; Wei S; Ma Y; Su J; Ren Z
Kidney Blood Press Res; 2022; 47(12):702-710. PubMed ID: 36260980
[TBL] [Abstract][Full Text] [Related]
19. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
Huang J; Sun X; Diao G; Li R; Guo J; Han J
Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
[TBL] [Abstract][Full Text] [Related]
20. Identification of circATG9A as a novel biomarker for renal cell carcinoma.
Shen Y; Wu R; Zhuo Z; Deng X; Li W; Liu C
Cancer Gene Ther; 2024 Jan; 31(1):82-93. PubMed ID: 37945969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]